{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:30:54Z","timestamp":1777599054575,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7242053"],"award-info":[{"award-number":["7242053"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7254350"],"award-info":[{"award-number":["7254350"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["EYGF-XY-06"],"award-info":[{"award-number":["EYGF-XY-06"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Jornal de Pediatria"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jped.2025.101466","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:53:21Z","timestamp":1762044801000},"page":"101466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral immune indicators and their predictive value in disease progression or relapse of pediatric Langerhans cell histiocytosis"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5834-783X","authenticated-orcid":false,"given":"Hua-Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2413-8084","authenticated-orcid":false,"given":"Hong-Yun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4615-2410","authenticated-orcid":false,"given":"Wen-Yu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0814-0142","authenticated-orcid":false,"given":"Shuo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5860-0696","authenticated-orcid":false,"given":"Wei-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-5743","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-8757","authenticated-orcid":false,"given":"Chan-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0114-9008","authenticated-orcid":false,"given":"Hong-Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5520-8867","authenticated-orcid":false,"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-4677","authenticated-orcid":false,"given":"Yun-Ze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-0379","authenticated-orcid":false,"given":"Zi-Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5721-5817","authenticated-orcid":false,"given":"Jia-Jia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5334-9706","authenticated-orcid":false,"given":"Zhi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-1431","authenticated-orcid":false,"given":"Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jped.2025.101466_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"16","key":"10.1016\/j.jped.2025.101466_bib0002","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"Rodriguez-Galindo","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jped.2025.101466_bib0003","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jped.2025.101466_bib0004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5858\/arpa.2023-0236-OA","article-title":"Genetic landscape and its prognostic impact in children with Langerhans cell histiocytosis","volume":"149","author":"Wang","year":"2025","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.jped.2025.101466_bib0005","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.14140","article-title":"Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age","volume":"174","author":"Rigaud","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jped.2025.101466_bib0006","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ajh.26829","article-title":"Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: results from the BCH-LCH 2014 protocol study","volume":"98","author":"Cui","year":"2023","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jped.2025.101466_bib0007","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","article-title":"Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study","volume":"4","author":"Diamond","year":"2018","journal-title":"JAMA Oncol"},{"issue":"31","key":"10.1016\/j.jped.2025.101466_bib0008","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.19.00456","article-title":"Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study","volume":"37","author":"Donadieu","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jped.2025.101466_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2018.06.004","article-title":"A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis","volume":"194","author":"Mitchell","year":"2018","journal-title":"Clin Immunol"},{"issue":"13","key":"10.1016\/j.jped.2025.101466_bib0010","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood.2020005867","article-title":"Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH","volume":"137","author":"Sengal","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jped.2025.101466_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12950","article-title":"Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis","volume":"92","author":"Paredes","year":"2020","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jped.2025.101466_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108418","article-title":"Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity","volume":"215","author":"Mitchell","year":"2020","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.jped.2025.101466_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41590-019-0558-z","article-title":"The coming of age of Langerhans cell histiocytosis","volume":"21","author":"Allen","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jped.2025.101466_bib0014","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cyto.2017.05.026","article-title":"Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis","volume":"97","author":"Morimoto","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jped.2025.101466_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156378","article-title":"Immune microenvironment associated with the severity of Langerhans cell histiocytosis in children","volume":"171","author":"Cai","year":"2023","journal-title":"Cytokine"},{"issue":"13","key":"10.1016\/j.jped.2025.101466_bib0016","doi-asserted-by":"crossref","first-page":"11431","DOI":"10.1007\/s00432-023-04991-w","article-title":"Serum levels of soluble interleukin 2 receptor (sIL-2R), tumor necrosis factor-alpha (TNF-\u03b1), and immunoglobulin M are correlated with the disease extent in childhood Langerhans cell histiocytosis","volume":"149","author":"Wang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.jped.2025.101466_bib0017","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jped.2024.08.005","article-title":"The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis","volume":"101","author":"Zhao","year":"2025","journal-title":"J Pediatr (Rio J)"},{"issue":"3","key":"10.1016\/j.jped.2025.101466_bib0018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ped4.12297","article-title":"A brief introduction to the FUTang updating medical REcords (FUTURE) database","volume":"5","author":"Wang","year":"2021","journal-title":"Pediatr Investig"},{"issue":"2","key":"10.1016\/j.jped.2025.101466_bib0019","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"10.1016\/j.jped.2025.101466_bib0020","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"H\u00e9ritier","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jped.2025.101466_bib0021","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14656566.2018.1429405","article-title":"An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy","volume":"19","author":"Minkov","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.jped.2025.101466_bib0022","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/bloodadvances.2021005442","article-title":"Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis","volume":"6","author":"Eder","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jped.2025.101466_bib0023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"issue":"15","key":"10.1016\/j.jped.2025.101466_bib0024","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2018-10-878363","article-title":"Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition","volume":"133","author":"Eckstein","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jped.2025.101466_bib0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12185-021-03205-8","article-title":"Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA","volume":"114","author":"Evseev","year":"2021","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jped.2025.101466_bib0026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jped.2025.101466_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1275085","article-title":"Langerhans cell histiocytosis: current advances in molecular pathogenesis","volume":"14","author":"Sconocchia","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jped.2025.101466_bib0028","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.jped.2025.101466_bib0029","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J Exp Med"}],"container-title":["Jornal de Pediatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002175572500155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002175572500155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:47:37Z","timestamp":1777409257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002175572500155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S002175572500155X"],"URL":"https:\/\/doi.org\/10.1016\/j.jped.2025.101466","relation":{},"ISSN":["0021-7557"],"issn-type":[{"value":"0021-7557","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral immune indicators and their predictive value in disease progression or relapse of pediatric Langerhans cell histiocytosis","name":"articletitle","label":"Article Title"},{"value":"Jornal de Pediatria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jped.2025.101466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Pediatria.","name":"copyright","label":"Copyright"}],"article-number":"101466"}}